BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Underhill GH, Khetani SR. Emerging trends in modeling human liver disease in vitro. APL Bioeng 2019;3:040902. [PMID: 31893256 DOI: 10.1063/1.5119090] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Lee SY, Kim D, Lee SH, Sung JH. Microtechnology-based in vitro models: Mimicking liver function and pathophysiology. APL Bioeng 2021;5:041505. [PMID: 34703969 DOI: 10.1063/5.0061896] [Reference Citation Analysis]
2 Kukla DA, Khetani SR. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Semin Liver Dis 2021;41:368-92. [PMID: 34139785 DOI: 10.1055/s-0041-1731016] [Reference Citation Analysis]
3 Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater 2020;116:67-83. [PMID: 32890749 DOI: 10.1016/j.actbio.2020.08.041] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 20.0] [Reference Citation Analysis]
4 Hadjittofi C, Feretis M, Martin J, Harper S, Huguet E. Liver regeneration biology: Implications for liver tumour therapies. World J Clin Oncol 2021; 12(12): 1101-1156 [DOI: 10.5306/wjco.v12.i12.1101] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu X, Du Q, Tian C, Tang M, Jiang Y, Wang Y, Cao Y, Wang Z, Wang Z, Yang J, Li Y, Jiao X, Xie P. Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma. Bioorg Chem 2021;107:104536. [PMID: 33342565 DOI: 10.1016/j.bioorg.2020.104536] [Reference Citation Analysis]
6 Gurevich I, Burton SA, Munn C, Ohshima M, Goedland ME, Czysz K, Rajesh D. iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery. Biol Open 2020;9:bio055087. [PMID: 33268331 DOI: 10.1242/bio.055087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Arteel GE, Naba A. The liver matrisome - looking beyond collagens. JHEP Rep 2020;2:100115. [PMID: 32637906 DOI: 10.1016/j.jhepr.2020.100115] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
8 Monckton CP, Brown GE, Khetani SR. Latest impact of engineered human liver platforms on drug development. APL Bioeng 2021;5:031506. [PMID: 34286173 DOI: 10.1063/5.0051765] [Reference Citation Analysis]
9 Kukla DA, Stoppel WL, Kaplan DL, Khetani SR. Assessing the compatibility of primary human hepatocyte culture within porous silk sponges. RSC Adv 2020;10:37662-74. [DOI: 10.1039/d0ra04954a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Faccioli LAP, Kocas-Kilicarslan ZN, Diaz-Aragon R, Motomura T, Amirneni S, Malizio MR, Coard MC, Frau C, Haep N, Florentino RM, Ostrowska A. Human Hepatocytes Isolated from Explanted Livers: A Powerful Tool to Understand End-stage Liver Disease and Drug Screening. Organogenesis 2021;17:117-25. [PMID: 35114888 DOI: 10.1080/15476278.2021.1992216] [Reference Citation Analysis]
11 Agarwal T, Borrelli MR, Makvandi P, Ashrafizadeh M, Maiti TK. Paper-Based Cell Culture: Paving the Pathway for Liver Tissue Model Development on a Cellulose Paper Chip. ACS Appl Bio Mater 2020;3:3956-74. [DOI: 10.1021/acsabm.0c00558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
12 Schepers AG, Shan J, Cox AG, Huang A, Evans H, Walesky C, Fleming HE, Goessling W, Bhatia SN. Identification of NQO2 As a Protein Target in Small Molecule Modulation of Hepatocellular Function. ACS Chem Biol 2021;16:1770-8. [PMID: 34427427 DOI: 10.1021/acschembio.1c00503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]